Announcements
- OpGen Announces Acquisition of Preferred Stock by David Lazar
- OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update
- OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds
- OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update
- OpGen’s Subsidiary Ares Genetics Releases New Features to its AREScloud Offering
- OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration Agreement
- OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. Eastern Time
- OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FIND
More ▼
Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 2.60 |
Average volume | -- |
---|---|
Shares outstanding | 10.01m |
Free float | 9.97m |
P/E (TTM) | -- |
Market cap | 7.18m USD |
EPS (TTM) | -6.51 USD |
Data delayed at least 15 minutes, as of Jan 06 2023 07:25 GMT.
More ▼